That’s why we’ve just released our revised Strategic Plan (you can find it on our website here), a kind of blueprint, if you will, for the next phase of our work. It lays out in very simple terms what we have achieved so far and where we want to go. That list of goals includes:
- Fund at least 10 therapies in early phase clinical trials that impact at least five diseases
- Attract the best scientists in the world to join us in creating discoveries that will shape biology and medicine for the future
- Create partnerships with industry, and leverage our dollars to speed up the development of therapies to be tested in people
- Create specialized stem cell clinics in California that can carry out clinical trials and deliver new therapies to patients
- Fund Centers of Excellence in stem cell genetics to take advantage of rapid developments in genetics and health
- Develop a strong support network with the Californian patient advocate community to keep them informed about clinical trials and the scientific progress being made
- Work closely with state and local governments to attract new research and biotech companies to California
- Promote our Bridges Training and Creativity programs to offer opportunities to students representing the diversity of California’s population who are hoping to pursue a career in science and research
- Work with companies to ensure that financial benefits from CIRM-funded discoveries go to the state’s General Fund
The field of stem cell research has changed in some dramatic ways since CIRM was created by Proposition 71 in 2004. We have to adapt to those changes, and plan for an ever-changing landscape if we are going to use our resources—taxpayer dollars—as effectively as possible.
Proposition 71 placed California at the center of stem cell research not just in the U.S. but worldwide. This Strategic Plan aims to keep us there. And while the plan introduces some new elements, our goals remain the same; to accelerate the research and development of therapies to improve the lives of patients.